 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 質(zhì)控品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：V900700 |
| 產(chǎn)品名稱：VX 809 |
| 產(chǎn)品CAS：936727-05-8 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
V900700 |
| 名稱: |
VX 809 |
| 別名: |
3-[6-[[[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl]amino]-3-methyl-2-pyridinyl]benzoic Acid; Lumacaftor; VRT 826809; |
| CAS號(hào): |
936727-05-8 |
| 分子式: |
C??H??F?N?O? |
| 外觀: |
白色至白色固體 |
| 熔點(diǎn): |
200-205ºC |
| 分子量: |
452.51 |
| 儲(chǔ)存: |
-20°C Freezer |
| 溶解度: |
DMSO (Slightly), Methanol (Slightly) |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
VX 809 is used in the stabilization of the CFTR protein used in the treatment of cystic fibrosis. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
|
|
